Literature DB >> 2536163

Characterization of a cDNA clone encoding the visna virus transactivating protein.

J L Davis1, J E Clements.   

Abstract

The unique pathogenesis of lentiviral infections in humans and ruminant animals may be explained, in part, by the complex mechanisms regulating transcription and translation of their viral genes. This report demonstrates that a visna virus-encoded protein transactivates viral gene expression. A 1.4-kilobase cDNA clone encodes two distinct proteins with apparent molecular masses of 21.5 and 10 kDa. We demonstrate that the 10-kDa species is the visna virus transactivating (Tat) protein; the other species may be analogous to the rev (formerly art or trs) gene product of human immunodeficiency virus.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2536163      PMCID: PMC286480          DOI: 10.1073/pnas.86.2.414

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Nucleotide sequence of the visna lentivirus: relationship to the AIDS virus.

Authors:  P Sonigo; M Alizon; K Staskus; D Klatzmann; S Cole; O Danos; E Retzel; P Tiollais; A Haase; S Wain-Hobson
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

2.  The trans-activator gene of the human T cell lymphotropic virus type III is required for replication.

Authors:  A I Dayton; J G Sodroski; C A Rosen; W C Goh; W A Haseltine
Journal:  Cell       Date:  1986-03-28       Impact factor: 41.582

3.  Transcription of novel open reading frames of AIDS retrovirus during infection of lymphocytes.

Authors:  A B Rabson; D F Daugherty; S Venkatesan; K E Boulukos; S I Benn; T M Folks; P Feorino; M A Martin
Journal:  Science       Date:  1985-09-27       Impact factor: 47.728

4.  Tropism of sheep lentiviruses for monocytes: susceptibility to infection and virus gene expression increase during maturation of monocytes to macrophages.

Authors:  H E Gendelman; O Narayan; S Kennedy-Stoskopf; P G Kennedy; Z Ghotbi; J E Clements; J Stanley; G Pezeshkpour
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

5.  The trans-activator gene of HTLV-III is essential for virus replication.

Authors:  A G Fisher; M B Feinberg; S F Josephs; M E Harper; L M Marselle; G Reyes; M A Gonda; A Aldovini; C Debouk; R C Gallo
Journal:  Nature       Date:  1986 Mar 27-Apr 2       Impact factor: 49.962

6.  Transactivation induced by human T-lymphotropic virus type III (HTLV III) maps to a viral sequence encoding 58 amino acids and lacks tissue specificity.

Authors:  L J Seigel; L Ratner; S F Josephs; D Derse; M B Feinberg; G R Reyes; S J O'Brien; F Wong-Staal
Journal:  Virology       Date:  1986-01-15       Impact factor: 3.616

7.  A second post-transcriptional trans-activator gene required for HTLV-III replication.

Authors:  J Sodroski; W C Goh; C Rosen; A Dayton; E Terwilliger; W Haseltine
Journal:  Nature       Date:  1986 May 22-28       Impact factor: 49.962

8.  cis- and trans-acting transcriptional regulation of visna virus.

Authors:  J L Hess; J E Clements; O Narayan
Journal:  Science       Date:  1985-08-02       Impact factor: 47.728

9.  Trans-activator gene of human T-lymphotropic virus type III (HTLV-III).

Authors:  S K Arya; C Guo; S F Josephs; F Wong-Staal
Journal:  Science       Date:  1985-07-05       Impact factor: 47.728

10.  Slow, persistent replication of lentiviruses: role of tissue macrophages and macrophage precursors in bone marrow.

Authors:  H E Gendelman; O Narayan; S Molineaux; J E Clements; Z Ghotbi
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

View more
  35 in total

Review 1.  Mechanism of action of regulatory proteins encoded by complex retroviruses.

Authors:  B R Cullen
Journal:  Microbiol Rev       Date:  1992-09

2.  Nucleotide sequence analysis of feline immunodeficiency virus: genome organization and relationship to other lentiviruses.

Authors:  R A Olmsted; V M Hirsch; R H Purcell; P R Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

3.  Comparison of two host cell range variants of feline immunodeficiency virus.

Authors:  T R Phillips; R L Talbott; C Lamont; S Muir; K Lovelace; J H Elder
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

4.  Conserved functional organization of the human immunodeficiency virus type 1 and visna virus Rev proteins.

Authors:  L S Tiley; M H Malim; B R Cullen
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

5.  Analysis of the transcription pattern and mapping of the putative rev and env splice junctions of bovine immunodeficiency-like virus.

Authors:  M S Oberste; J D Greenwood; M A Gonda
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

6.  Effector domains of human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex are functionally interchangeable and share an essential peptide motif.

Authors:  T J Hope; B L Bond; D McDonald; N P Klein; T G Parslow
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

7.  Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication.

Authors:  H Chen; J He; S Fong; G Wilcox; C Wood
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

8.  Analysis of regulatory elements of the equine infectious anemia virus and caprine arthritis-encephalitis virus long terminal repeats.

Authors:  L Sherman; A Yaniv; H Lichtman-Pleban; S R Tronick; A Gazit
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

9.  The maedi-visna virus Tat protein induces multiorgan lymphoid hyperplasia in transgenic mice.

Authors:  C Vellutini; V Philippon; D Gambarelli; N Horschowski; K A Nave; J M Navarro; M Auphan; M A Courcoul; P Filippi
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

10.  Two species of Rev proteins, with distinct N termini, are expressed by caprine arthritis encephalitis virus.

Authors:  A Gazit; P Mashiah; H Kalinski; A Gast; R Rosin-Abersfeld; S R Tronick; A Yaniv
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.